Light can carry enormous amounts of information at extreme speeds, making photonic technologies promising for the development ...

Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc.

Anthropic’s new Claude research reveals a hidden internal “global workspace” that resembles human conscious processing, ...

The expanding interest in small bioactive peptides has brought renewed attention to glycyl-L-histidyl-L-lysine bound to ...

New Preclinical Data Demonstrate Favorable Oral Bioavailability, Robust Brain Penetration and Liver Exposure with ...

TrojPix uses imperceptible pixel modulation so copper video cables radiate data, hitting 8.1 Mbps in lab tests with a nearby ...

Engineered copper nanoclusters steer CO2 electroreduction away from unwanted formate and toward methanol, advancing cleaner ...

Immunomic Therapeutics begins patient dosing in phase 1 trial of ITI-9001 to treat Japanese cedar pollen allergy: Rockville, Maryland Monday, July 6, 2026, 11:00 Hrs [IST] Immunom ...

Cohere Technologies was awarded a $28 million contract by the Department of Defense (DoD) to develop radio access network (RAN) technologies to advance 5G/6G infrastructure. The contract will support ...

A financial analysis has sparked debate after suggesting that a monthly salary of R100k may not be enough to support a family ...

Immunomic Therapeutics Inc. (ITI), a clinical-stage biotechnology company and a subsidiary of HLB, today announced that the first participant has been dosed in the Phase 1 clinical trial of ITI-9001, ...

Neuromodulation is a breakthrough technology that can help those with chronic pain, PTSD, and other conditions. This facility ...